Orange Book product
AMPICILLIN SODIUM EQ 250MG BASE/VIAL
Orange Book ANDA 090583 · SAGENT PHARMACEUTICALS INC · Prescription
Key facts
| Proprietary name | AMPICILLIN SODIUM |
|---|---|
| Active ingredients | AMPICILLIN SODIUM |
| Strength | EQ 250MG BASE/VIAL |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Application | ANDA090583 |
| Applicant holder | SAGENT PHARMACEUTICALS INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AP |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Nov 27, 2015 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.